Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.

Cindy Franklin, Peter Mohr, Leonie Bluhm, Imke Grimmelmann, Ralf Gutzmer, Friedegund Meier, Marlene Garzarolli, Michael Weichenthal, Claudia Pfoehler, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Jens Ulrich, Dirk Debus (Co-author), Sebastian Haferkamp, Martin Kaatz, Andrea Forschner, Ulrike Leiter, Dorothee Nashan, Alexander KreuterMichael Sachse, Julia Welzel, Lucie Heinzerling, Frank Meiss, Carsten Weishaupt, Thilo Gambichler, Gerhard Weyandt, Edgar Dippel, Kerstin Schatton, Eren Celik, Maike Trommer, Iris Helfrich, Alexander Roesch, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Susanne Horn, Selma Ugurel

Research output: Contribution to journalOriginal Articlepeer-review

17 Citations (Web of Science)
Original languageEnglish
JournalJOURNAL FOR IMMUNOTHERAPY OF CANCER
Volume10
Issue number6
DOIs
Publication statusPublished - 2022

Keywords

  • STEREOTACTIC RADIOSURGERY
  • CEREBRAL METASTASES
  • MALIGNANT-MELANOMA
  • RADIATION NECROSIS
  • CLINICAL-OUTCOMES
  • OPEN-LABEL
  • IPILIMUMAB
  • INHIBITION

Cite this